Merck & Co., Inc. (NYSE:MRK) is included among the 10 Reliable Dividend Stocks to Buy for Long-Term Investors. On June 24, ...

Before its fifty percent surge, the drug giant was repeatedly telling a story about its future that the market seemed to be ...

Mixed stock index futures as tech rebounds: watch Micron earnings, Merck’s Keytruda approval, Wendy’s WSB surge, and ...

Bio-Techne stock jumps, with Germany’s Merck KGaA buying the company at a 24% premium.

Merck looks like a buy-the-dip at $114.90 with a 3% yield and 12x forward P/E. Click here to read more on the MRK stock.

Merck (NYSE: MRK) has taken its shareholders on a wild ride of late -- from last March's record high of more than $130 to this May's low near $76 back to its current price of just a little more than ...

Merck’s MRK stock climbed above its 50-day SMA from early June after trading below it for most of May. However, the stock has ...

Merck stock jumps almost 14% as investor optimism grew after Pfizer's drug pricing deal. The deal boosts sector sentiment by reducing drug costs and driving investment in the U.S. pharma sector.

Merck (MRK Quick Quote MRK - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term ...

Merck remains in focus as combination therapy development and pipeline progress shape the broader healthcare landscape.

Merck & Co., Inc. (NYSE:MRK) is one of the 10 Undervalued Counter Cyclical Stocks to Buy Now.

Merck & Co., Inc. (NYSE:MRK) is included among the Billionaire Ken Fisher’s Top 11 Dividend Stock Picks. Reuters reported on ...